2024 annual financial data
UroGen Pharma 2024 Net margin
Direct answer
Net margin was -140.35%.
Operating income was -96,782,000 USD and net income was -126,874,000 USD.
Operating cash flow was -96,766,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 90,398,000 USD
- Operating income
- -96,782,000 USD
- Net income
- -126,874,000 USD
- Operating cash flow
- -96,766,000 USD